NASDAQ: MURA - Mural Oncology plc

六个月盈利: -62.3%
股息率: 0.00%

促销时间表 Mural Oncology plc

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Mural Oncology plc

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs.

更多详情
Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2023-11-16
ISIN IE000LK2BOB4
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.muraloncology.com
Цена ао 1.33
每日价格变化: -12.59% (1.35)
每周价格变化: -69.35% (3.85)
每月价格变化: -68.87% (3.79)
3个月内价格变化: -63.35% (3.22)
六个月内的价格变化: -62.3% (3.13)
每年价格变化: -75.87% (4.89)
年初以来价格变化: -63.35% (3.22)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0.3745 10
P/E 0 0
EV/EBITDA 0.8176 10
全部的: 5

效率

姓名 意义 年级
ROA, % -68.75 0
ROE, % -78.63 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0781 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 10.82 2
盈利能力 EPS, % 18.26 3
全部的: 2.4
更多详情

机构 体积 分享, %
Westfield Capital Management Co LP 1985886 11.9
Bank Of New York Mellon Corporation 399462 2.39
PRIMECAP Management Company 256255 1.54
Dimensional Fund Advisors LP 238482 1.43
HRT Financial LP 201934 1.21
Artisan Partners Limited Partnership 185432 1.11
Norges Bank Investment Management 168511 1.01
Charles Schwab Investment Management, Inc. 81208 0.49
PanAgora Asset Management, Inc. 63924 0.38
Connor Clark & Lunn Investment Management Ltd 51162 0.31

ETF分享, %本年盈利能力, %股息, %
iShares Micro-Cap ETF 0.0142 17.09 1.54048
Schwab 1000 Index ETF 0.0001 25.15 1.42441
0.0121.121.48

导师 职称 支付 出生年份
Ms. Caroline J. Loew Ph.D. President, CEO & Director 303.29k 1971 (54 年)
Mr. Adam D. Cutler B.A. CFO, Principal Financial Officer & Principal Accounting Officer 496.65k 1975 (50 年)
Ms. Maiken Keson-Brookes Chief Legal Officer N/A 1973 (52 年)
Mr. Justin Levine Head of Human Resources & VP of Human Resources N/A
Dr. Vicki L. Goodman M.D. Chief Medical Officer 578.34k 1971 (54 年)

地址: Ireland, Dublin D T, 10 Earlsfort Terrace - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.muraloncology.com